We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.59%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$169M
AUM Growth
-$13M
(-7.2%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-10.58%
Top 10 Holdings %
Top 10 Hldgs %
6.26%
Holding
495
New
55
Increased
122
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$947K |
| 2 |
Moderna
MRNA
|
+$899K |
| 3 |
Meta Platforms (Facebook)
META
|
+$895K |
| 4 |
Netflix
NFLX
|
+$876K |
| 5 |
Chipotle Mexican Grill
CMG
|
+$852K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.01M |
| 2 |
Progressive
PGR
|
+$999K |
| 3 |
Stryker
SYK
|
+$984K |
| 4 |
Republic Services
RSG
|
+$973K |
| 5 |
Linde
LIN
|
+$966K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.98% |
| 2 | Technology | 15.96% |
| 3 | Financials | 11.34% |
| 4 | Energy | 8.43% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Recursion Pharmaceuticals
RXRX
$1.6B
| $82.4K | 0.05% |
11,028
-57
| -0.5% | -$399 |
|
427
Pliant Therapeutics
PLRX
$66.9M
| $81K | 0.05% |
4,469
-810
| -15% | -$19.2K |
|
|
TERN
428
DELISTED
Terns Pharmaceuticals
TERN
| $80.8K | 0.05% |
+9,239
| New | +$108K |
|
429
Editas Medicine
EDIT
$411M
| $80.7K | 0.05% |
9,805
+36
| +0.4% | +$314 |
|
430
Viking Therapeutics
VKTX
$4.05B
| $78.7K | 0.05% |
+4,857
| New | +$102K |
|
431
uniQure
QURE
$2.63B
| $64.3K | 0.04% |
5,611
+1,305
| +30% | +$24.7K |
|
432
Biomea Fusion
BMEA
$91.1M
| $61.4K | 0.04% |
+2,795
| New | +$87.5K |
|
|
MRSN
433
DELISTED
Mersana Therapeutics
MRSN
| $37.5K | 0.02% |
455
-112
| -20% | -$16.4K |
|
434
BioXcel Therapeutics
BTAI
$26.8M
| $34K | 0.02% |
319
-12
| -4% | -$4K |
|
|
KYNB
435
Kyntra Bio
KYNB
$28.5M
| $17.9K | 0.01% |
265
-3
| -1% | -$1.24K |
|
436
Adicet Bio
ACET
$75.3M
| – | – |
-594
| Closed | -$54.8K |
|
437
Archer Daniels Midland
ADM
$40.1B
| – | – |
-10,521
| Closed | -$838K |
|
438
Aflac
AFL
$64.4B
| – | – |
-12,406
| Closed | -$800K |
|
|
AFMD
439
DELISTED
Affimed
AFMD
| – | – |
-8,575
| Closed | -$63.9K |
|
440
Altimmune
ALT
$576M
| – | – |
-9,389
| Closed | -$39.6K |
|
441
Atara Biotherapeutics
ATRA
$69.5M
| – | – |
-1,043
| Closed | -$75.6K |
|
442
Brown & Brown
BRO
$23.6B
| – | – |
-14,323
| Closed | -$822K |
|
443
C4 Therapeutics
CCCC
$397M
| – | – |
-12,350
| Closed | -$38.8K |
|
444
CDW
CDW
$17.6B
| – | – |
-4,438
| Closed | -$865K |
|
445
Codexis
CDXS
$141M
| – | – |
-18,136
| Closed | -$75.1K |
|
446
Church & Dwight Co
CHD
$23.4B
| – | – |
-10,639
| Closed | -$941K |
|
447
Check Point Software Technologies
CHKP
$13.6B
| – | – |
-6,877
| Closed | -$894K |
|
448
Centene
CNC
$31.6B
| – | – |
-11,709
| Closed | -$740K |
|
449
CSX Corp
CSX
$96B
| – | – |
-27,690
| Closed | -$829K |
|
450
Quest Diagnostics
DGX
$25.6B
| – | – |
-6,037
| Closed | -$854K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
ALS
Virtus ETF Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, Virtus ETF Advisers held 495 positions worth $169M, down 7.2% from $182M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Virtus ETF Advisers withdrew a net $17.8M in Q2 2023, closing 60 positions and reducing 257 holdings. Its most notable exit was Activision Blizzard, an estimated $1.01M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
Against the trend, Virtus ETF Advisers opened a new position in NVIDIA worth $1.21M.
- Virtus ETF Advisers's largest Q2 2023 buy was NVIDIA: 28,520 shares worth $1.21M.
- Virtus ETF Advisers added most to Moderna in Q2 2023, an estimated $899K increase.
- Virtus ETF Advisers's biggest Q2 2023 reduction was Dow Inc, cutting an estimated $898K.
- Virtus ETF Advisers fully exited Activision Blizzard in Q2 2023, selling an estimated $1.01M.
- Virtus ETF Advisers's ten largest holdings make up 6.3% of its $169M portfolio in Q2 2023.
- Virtus ETF Advisers opened 55 new positions and closed 60 in Q2 2023.
- Virtus ETF Advisers's portfolio value fell 7.2% quarter-over-quarter to $169M.
Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.